Andrew Witty, UnitedHealth CEO, said the move will remove an excuse other players use to blame Optum Rx for high drug costs.
Mattingly is an associate professor and vice chair of research in the Department of Pharmacotherapy at the University of Utah ...
On Tuesday, the Federal Trade Commission released its second interim staff report on prescription drug middlemen. The report ...
House Energy Chair Brett Guthrie said he hopes to revive the health legislation that was pushed out of the American Relief ...
The time is right for PBM reform, but the American people might be better served if Congress goes back to the drawing board ...
The pharmaceutical supply chain is a sector infamous for glacially slow adjustments, lackluster reform, lack of transparency ...
Says that while the company offers customers 100% pass-through options, “a small number have historically elected other models.” Witty says “We ...
The FDC released a second highly critical report of PBMs, which may provide further impetus for legislative action to curb ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback